AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Riot Platforms, Inc. Director's Dealing 2010

Jan 21, 2010

30793_dirs_2010-01-21_2323ba13-ee98-4e6f-9847-500fb1d44cb9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2010-01-19

Reporting Person: Bennett Gregory L (SVP - Manufacturing & Prod Dev)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option - Right to Buy	$2.09	2019-09-15	Common Stock (200000)		Direct

Footnotes

F1: The option to purchase 200,000 shares of common stock shall become exercisable as to 25% of the shares on each of March 15,
2010, September 15, 2010, September 15, 2011 and September 15, 2012.